123I-Interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease

Journal of Nuclear Medicine

Volumn 41, Issue 2, 2000, Pages 242-249

  Signore, Alberto ^a   Chianelli, Marco ^b   Annovazzi, Alessio ^b   Bonanno, Elena ^b   Spagnoli, Luigi G ^b   Pozzilli, Paolo ^b   Pallone, Francesco ^b   Biancone, Livia ^b  

^a POLICLINICO UMBERTO I   (Italy)

^b NONE

Author keywords

Crohn's disease; Interleukin 2; Mucosal lymphocytes; Scintigraphy

Indexed keywords

INTERLEUKIN 2 RECEPTOR; IODINE 123; IODINE 125; RECOMBINANT INTERLEUKIN 2; STEROID; DIAGNOSTIC AGENT; INTERLEUKIN 2; RADIOACTIVE IODINE;

ADULT; AGED; ARTICLE; AUTORADIOGRAPHY; CELL ACTIVATION; CELL INFILTRATION; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DISEASE ACTIVITY; DRUG BINDING; FEMALE; HUMAN; HUMAN TISSUE; ILEUM MUCOSA; IMMUNOSCINTIGRAPHY; INTESTINE WALL; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; REMISSION; SCINTILLATION CAMERA; STEROID THERAPY; CASE CONTROL STUDY; ILEUM; METABOLISM; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; AUTORADIOGRAPHY; CASE-CONTROL STUDIES; CROHN DISEASE; FEMALE; HUMANS; ILEUM; INTERLEUKIN-2; IODINE RADIOISOTOPES; MALE; RECEPTORS, INTERLEUKIN-2; SENSITIVITY AND SPECIFICITY;

EID: 0033621982     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Pallone F, Montano S, Fais S, Boirivant M, Signore A, Pozzilli P. Studies of peripheral blood lymphocytes in Crohn's disease. Circulating activated T cells. Scand J Gastroenterol. 1983;18:1003-1008.
2. Schreiber S, Nash GS, Bertovich M, MacDermott RP. Activation of human lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology. 1991;101:1021-1030.
3. Pallone F, Fais S, Squarcia O, Biancone L, Pozzilli P, Boirivant M. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease: in vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut. 1987;28:745-753.
4. Choy MY, Walker-Smith JA, Williams CB, McDonald TT. Differential expression of CD25 (interleukin-2 receptor) on lamina propria T cells and machrophages in the intestinal lesions in Crohn's disease and ulcerative colitis. Gut. 1990;31:1365-1370.
5. Mueller C, Knoflach P, Zielinski CC. T cell activation in Crohn's disease: increased levels of soluble interleukin-2 receptor in serum and supernatants of stimulated peripheral blood mononuclear cells. Gastroenterology. 1990;98:639-646.
6. Louis E, Belaiche J, Van Kemseke C, Schaaf N, Mathieu P, Mary JW. Soluble interleukin 2 receptor in Crohn's disease: assessment of disease activity and prediction of relapse. Dig Dis Sci. 1995;40:1730-1756.
7. 123I-interleukin-2: an early sign of type 1 diabetes. Lancet. 1987;2:537-540.
8. 123I-interleukin-2 - labelling procedure and animal studies. Nucl Med Commun. 1992;13:713-722.
9. 123I labelled interleukin-2. Eur J Endocrinol. 1994;131:431-437.
10. Best WR, Becklel JM, Singleton JW, Kern F. Development of a Crohn's Disease Activity Index. National Cooperative Crohn's Disease study. Gastroenterology. 1976;70:439-434.
11. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet. 1980;1:514.
12. Pallone F, Ricci F, Boirivant M, Montano S. Measuring the activity of Crohn's disease. It J Gastroenterol. 1981;13:51-53.
13. Boirivant M, Pallone F, Ciaco A, Leoni M, Fais S, Torsoli A. Usefulness of fecal α1-antitrypsin clearance and fecal concentration as early indicator of postoperative asymptomatic recurrence in Crohn's disease. Dig Dis Sci. 1991;36:347-352.
14. Biancone L, Mandal A, Yang H, et al. Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology. 1995;109:3-12.
15. Konrad MW, Hemstreet G, Hersh ED, et al. Pharmacokinetics of recombinant interleukin-2 in humans. Cancer Res. 1990;50:2009-2017.
16. Van Dullemen HM, Van Deventer SJH, Hommes DW, et al. Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2). Gastroenterology. 1995;109:129-135.
17. Gibson P, Lichtensten M, Salehi N, Habberd G, Andrews J. Value of positive technetium 99m-leukocyte scans in predicting intestinal inflammation. Gut. 1991;32:1502-1507.
18. m-labelled human non-specific immunoglobulin in radionuclide imaging of rheumatoid arthritis. Br J Radiol. 1997;70:473-481.
19. Van der Laken CJ, Boerman OC, Oyen WJ, Van de Ven MT, Ven der Meer JW, Corstens FH. The kinetics of radiolabelled interleukin-8 in infection and sterile inflammation. Nucl Med Commun. 1998;19:271-281.
20. Robb RJ, Munck A, Smith KA. T-cell growth factor receptors: quantitation, specificity and biological relevance. J Exp Med. 1981;154:1455-1474.
21. Chianelli M, Signore A, Fritzberg AR, Mather SJ. The development of technetium-99m-labelled interleukin-2: a new radiopharmaceutical for the in vivo detection of mononuclear cell infiltrates in immune-mediated diseases. Nucl Med Biol. 1997;24:579-586.
22. Morson BC, Dawson IMP. Gastrointestinal Pathology. Oxford, UK: Blackwell Scientific Publications; 1979.
23. Modigliani R, Mary JY, Simon JF, et al. Clinical, biological and endoscopic pictures of attacks of Crohn's disease: evolution on prednisolone. Gastroenterology. 1990;98:811-818.
24. Schreiber S, Nikolaus S, Hampe J, et al. Tumor necrosis factor a and interleukin-1 β in relapse of Crohn's disease. Lancet. 1999;353:459-461.